XC

XCEL PHARMACEUTICALS INC

  • CIK: 0001139665
  • EIN: 33-0949894
  • Business address: 6363 GREENWICH DRIVE, SUITE 100, SAN DIEGO, California, 92121

Information

  • Mailing address
    6363 GREENWICH DRIVE, SUITE 100, SAN DIEGO, CA, 92122
  • Phone
    8582022700
  • State location
    California
  • State of incorporation
    N/A
  • Fiscal year end
    N/A
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About XCEL PHARMACEUTICALS INC

XCEL PHARMACEUTICALS INC (CIK: 0001139665) is an American company incorporated in the state of California. Head office is located at 6363 GREENWICH DRIVE, SUITE 100, SAN DIEGO, California, 92121. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. XCEL PHARMACEUTICALS INC is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by XCEL PHARMACEUTICALS INC

Filings Format Description Filed/Effective File/Film Number
RW Document

Registration Withdrawal Request

Acc-no: 0001193125-04-059493 ( Act) Size: 5 KB		 Apr-09-2004

333-108165

04726110
S-1/A Document

Amendment to General form of registration statement for all companies including face-amount certificate companies

Acc-no: 0001193125-03-055384 ( Act) Size: 2314 KB		 Sep-29-2003

333-108165

03915368
S-1 Document

General form of registration statement for all companies including face-amount certificate companies

Acc-no: 0001193125-03-041131 ( Act) Size: 3452 KB		 Aug-22-2003

333-108165

03862520
REGDEX Document Acc-no: 9999999997-03-020944 ( Act) Size: 1 KB May-08-2003

021-45600

03058468
RW Document

Registration Withdrawal Request

Acc-no: 0000898430-03-000315 ( Act) Size: 19 KB		 Jan-31-2003

333-76366

03534568
REGDEX Document Acc-no: 9999999997-02-041403 ( Act) Size: 1 KB Jul-05-2002

021-45600

02045647
S-1/A Document

Amendment to General form of registration statement for all companies including face-amount certificate companies

Acc-no: 0000898430-02-001538 ( Act) Size: 1451 KB		 Apr-19-2002

333-76366

02615913
S-1/A Document

Amendment to General form of registration statement for all companies including face-amount certificate companies

Acc-no: 0000898430-02-000467 ( Act) Size: 1177 KB		 Feb-08-2002

333-76366

02532563
S-1 Document

General form of registration statement for all companies including face-amount certificate companies

Acc-no: 0000950109-02-000119 ( Act) Size: 1761 KB		 Jan-07-2002

333-76366

2502868

Recent 20 filings. View all XCEL PHARMACEUTICALS INC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Frequently Asked Questions

Tags:

  • XCEL PHARMACEUTICALS INC overview
  • XCEL PHARMACEUTICALS INC job
  • XCEL PHARMACEUTICALS INC stock
  • XCEL PHARMACEUTICALS INC ownership
  • XCEL PHARMACEUTICALS INC CEO
  • XCEL PHARMACEUTICALS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Contineum Therapeutics, Inc.
Update: Mar 16, 2024
Cuprina Holdings (Cayman) LTD
Update: Mar 08, 2024
APRINOIA Therapeutics Inc.
Update: Jan 27, 2024
Zhengye Biotechnology Holding Ltd
Update: Jan 10, 2024
Alto Neuroscience, Inc.
Update: Nov 28, 2023
Mural Oncology plc
Update: Nov 02, 2023

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 2627 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 4206 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 4564 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 3365 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 1430 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 4899 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 4281 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 3534 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 4416 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by